Literature DB >> 27327402

Role of endovascular embolization in treatment of acute bleeding complications in haemophilia patients.

Shaileshkumar Garge1, Shyamkumar N Keshava1, Vinu Moses1, Suraj Mammen1, Munawwar Ahmed1, George Koshy Chiramel1, Vinoo Cherian2, Nithyananth Manasseh2, Biju George3, Vikram Mathews3, Aby Abraham3, Auro Viswabandya3, Alok Srivastava3, Sridhar Gibikote1.   

Abstract

OBJECTIVE: : Bleeding complications either spontaneously or post-operatively are very common in patients with haemophilia. Sometimes these bleeding complications remain unresponsive despite being on high dose of clotting factor replacement. The aim was to assess the role of endovascular embolization in patients with haemophilia in (a) treating haemorrhagic complications due to local causes refractory to clotting factors substitution and (b) reducing intraoperative blood loss in elective pseudotumour surgery.
METHODS: : 10 patients seen between January 2000 and April 2015 with severe haemophilia A or B who had unexplained profuse persistent bleeding or required large pseudotumour excision and were taken up for digital subtraction angiography and embolization were included in the study. Data of all these patients were reviewed using the computerized hospital information system and picture archiving and communication system. Details including indications for the procedure, patient preparation for the procedure, imaging findings, details of angiography with intervention, if any, and outcome as well as follow-up data were analyzed.
RESULTS: : In 6 of these 10 cases, bleeding was spontaneous, in 2 cases due to trivial fall and in 2 cases due to post-operative bleeding. Angiography in these patients revealed vascular blush, abnormal hypervascularity or active extravasation. In all 10 patients, an embolization procedure was performed, with bleeding controlled in 8 patients. There were no procedure-related complications during the procedure, post-procedure bleeding or haematoma at the site of arterial access. One patient had recurrence of bleeding for whom surgical exploration was required, and one patient had significant bleeding intraoperatively which was controlled with high-dose clotting factors, blood transfusion and fresh frozen plasma intraoperatively.
CONCLUSION: : Endovascular embolization is a safe, effective and cost-saving procedure in arresting bleeding in selected patients with severe haemophilia who are unresponsive to adequate clotting factor replacement and where local vascular causes could be contributing to the bleeding. Pre-operative embolization is also a good procedure to reduce intraoperative blood loss in patients with large pseudotumours. ADVANCES IN KNOWLEDGE:: Angiography and embolization in patients with haemophilia is technically challenging and should be performed by highly skilled interventional radiologists, which limits its wider use and familiarity among multidisciplinary teams managing haemophilia. By bringing the knowledge of this effective treatment to the specialist groups who care for patients with haemophilia, its wider application may be possible which can save life and/or reduce morbidity.

Entities:  

Year:  2016        PMID: 27327402      PMCID: PMC5124877          DOI: 10.1259/bjr.20151064

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Periarticular aneurysm following total knee replacement in hemophilic arthropathy. A case report.

Authors:  Haroon A Mann; Nicholas J Goddard; Christine A Lee; Simon A Brown
Journal:  J Bone Joint Surg Am       Date:  2003-12       Impact factor: 5.284

2.  Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization.

Authors:  Eveline P Mauser-Bunschoten; Jacco A C Zijl; Willem Mali; A Cees van Rinsum; H Marijke van den Berg; Goris Roosendaal
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  False aneurysm after arthroscopic meniscectomy. A report of two cases.

Authors:  G M Vincent; W D Stanish
Journal:  J Bone Joint Surg Am       Date:  1990-06       Impact factor: 5.284

4.  Aneurysm after arthroscopy.

Authors:  M P Manning; J H Marshall
Journal:  J Bone Joint Surg Br       Date:  1987-01

5.  Endoscopic injection treatment of gastrointestinal bleeding in hemophiliacs.

Authors:  J M Ziemski; A B Szczepanik; A Misiak; W J Rudowski
Journal:  World J Surg       Date:  1996 Nov-Dec       Impact factor: 3.352

6.  Successful angiographic embolization of recurrent elbow and knee joint bleeds in seven patients with severe haemophilia.

Authors:  R Klamroth; S Gottstein; E Essers; H Landgraf; M Wilaschek; J Oldenburg
Journal:  Haemophilia       Date:  2008-08-07       Impact factor: 4.287

7.  Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project.

Authors:  R Kulkarni; J M Soucie; J Lusher; R Presley; A Shapiro; J Gill; M Manco-Johnson; M Koerper; P Mathew; T Abshire; D Dimichele; K Hoots; R Janco; D Nugent; S Geraghty; B Evatt
Journal:  Haemophilia       Date:  2009-07-22       Impact factor: 4.287

  7 in total
  3 in total

1.  TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding.

Authors:  Tine Wyseure; Tingyi Yang; Jenny Y Zhou; Esther J Cooke; Bettina Wanko; Merissa Olmer; Ruchi Agashe; Yosuke Morodomi; Niels Behrendt; Martin Lotz; John Morser; Annette von Drygalski; Laurent O Mosnier
Journal:  JCI Insight       Date:  2019-10-03

2.  Availability of angiography and therapeutic embolization for the treatment of acute bleeding in patients with hemophilia.

Authors:  Mi Jin Kim; Ji Young Oh; Young Shil Park
Journal:  Int J Hematol       Date:  2017-08-16       Impact factor: 2.490

3.  Prostatic artery embolization in men with severe hemophilia a: a case report of two patients.

Authors:  Petra Svarc; Peter Kampmann; Lars Lönn; Martin Andreas Røder
Journal:  CVIR Endovasc       Date:  2022-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.